Diana Roettger, PhD, and Olga Kubassova, PhD[email protected]MRIAdvanced imaging offers insight into targeted therapiesMajor breakthroughs are emerging in the development of targeted therapies that use the body's own immune system to attack cancer cells. But traditional methods of measuring the success of drug candidates are slow and expensive. Could advanced imaging help? Diana Roettger, PhD, and Olga Kubassova, PhD, of the Image Analysis Group offer a perspective.February 5, 2019Page 1 of 1Top StoriesMRIMRI-based model shows changes over time in multiple myeloma patientsWhole-body MRI could serve as a scalable biomarker for risk stratification in multiple myeloma patients.UltrasoundThyroid nodule classification systems provide diagnostic equityInterventionalY-90 TARE rises to top in treatments for liver transplant patientsUltrasoundUltrasound MinnieCast, Episode 16: How to create a sonography associationISeConsult systems may benefit radiology-provider communication